| Top Articles |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Computers and Technology > Computers and Technology > Convert to C# - Opportunity Cost and Re-Writing Code |
|
Top Articles - Convert to C# - Opportunity Cost and Re-Writing Code
As a student of economics in my college days I learned quite a few fascinating principles. Well, m According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product aybe that’s not entirely true. If by “learned,” one means “acquired” and “retained,” then perhaps I ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in only really learned one principle. But it’s a good one: the principle of Opportunity Cost. Accordi lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. ng to Princeton’s WordNet, Opportunity Cost is defined as the “cost in terms of foregoing alternati here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe es.” As a programmer by profession, this principle came to mind recently as my employer was decidin d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro g whether to have me re-write a block of code from Delphi to C#, or have it converted by a third pa ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc rty. They were presented with a dilemma. Either have me spend months tediously converting thousand easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi s of lines of code, or fork out some cash to have a code conversion service do it for us. My initia nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically thought was, “hey, why spend money on this when I can do it myself? I’m qualified and knowledgeabl and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ e enough!” But I immediately realized that they would be spending money either way. The key questio ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi n became: How much is my time really worth? I spent a moment trying to figure that out myself. To ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a follow my thought process, let’s walk through some simple calculations. Let’s say my services/skill dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod are worth about $30/hr at my given profession and the project to convert this code takes 6 months cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin of full-time development. If I work 8 hour days for 6 months that means it will cost $28,800 to com tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Can You Really Make Money While You Sleep? Credit Card Debt Management - Helps Let Friends Be Friends
|